| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CTPS1_0004200 | Exon-Intergenic | chr1:41471723-41499798 | chr1:41006051-41034126 | 250 nt | 0.4040 |
| hsa_chr1_0869500 | Intergenic-Intergenic | chr1:41493522-41493863 | chr1:41027850-41028191 | 342 nt | 0.5906 |
| hsa_chr1_0869600 | Intergenic-Intergenic | chr1:41493753-41503116 | chr1:41028081-41037444 | 465 nt | 0.6086 |
| hsa_chr1_0869700 | Intergenic-Intergenic | chr1:41493760-41503116 | chr1:41028088-41037444 | 524 nt | 0.5782 |
| hsa_SCMH1_0000400 | Exon-Exon | chr1:41493829-41499720 | chr1:41028157-41034048 | 209 nt | 0.5311 |
| hsa_SCMH1_0000500 | Exon-Exon | chr1:41493829-41503213 | chr1:41028157-41037541 | 180 nt | 0.5833 |
| hsa_chr1_0869900 | Intergenic-Intergenic | chr1:41493919-41494331 | chr1:41028247-41028659 | 149 nt | 0.5705 |
| hsa_SCMH1_0000600 | Exon-Exon | chr1:41494256-41541123 | chr1:41028584-41075451 | 143 nt | 0.6084 |
| hsa_SCMH1_0001000 | Exon-Exon | chr1:41499655-41503213 | chr1:41033983-41037541 | 246 nt | 0.5244 |
| hsa_SCMH1_0001200 | Intron-Exon-Intron | chr1:41499655-41507237 | chr1:41033983-41041565 | 66 nt | 0.3636 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].